| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0024795f45a646ef64b3664ab8a26d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D273-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D273-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D273-00 |
| filingDate |
1985-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a4fb81a453a679789c432873fc1381e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3b4ee064180077db253010ad06f53ea |
| publicationDate |
1986-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0166986-A1 |
| titleOfInvention |
Disubstituted 3,7-diaryl-1,5,3,7-dioxadiazocines, and process for their preparation |
| abstract |
The invention relates to new disubstituted 3,7-diaryl-1,5,3,7-dioxodiazocines of the general formula <IMAGE> in which Ar is an aryl group substituted by an electron-withdrawing radical. These compounds are chemotherapy drugs, especially immune system stimulants. |
| priorityDate |
1984-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |